Transcription factors in islet development and physiology: Role of PDX-1 in beta-cell function

Annals of the New York Academy of Sciences

Volumn 1014, Issue , 2004, Pages 28-37

  Melloul, Danielle ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Beta cell; Diabetes; Insulin; Islet; Pancreas; PDX 1; Transcription factors

Indexed keywords

GLUCOSE; INSULIN; NEUROGENIC DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXA 2; TRANSCRIPTION FACTOR HB9; TRANSCRIPTION FACTOR HNF 1ALPHA; TRANSCRIPTION FACTOR ISL 1; TRANSCRIPTION FACTOR NGN3; TRANSCRIPTION FACTOR NKX 2.2; TRANSCRIPTION FACTOR NKX 6.1; TRANSCRIPTION FACTOR PAX4; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG;

AGENESIS; BINDING AFFINITY; CELL FUNCTION; CELL MATURATION; CELL TYPE; CORRELATION ANALYSIS; DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; HUMAN; KNOCKOUT GENE; MATURITY ONSET DIABETES MELLITUS; NONHUMAN; ORGANOGENESIS; PANCREAS; PANCREAS DEVELOPMENT; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PHENOTYPE; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TISSUE SPECIFICITY;

EID: 2342608007     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1294.003     Document Type: Review

References (79)

1. JONSSON, J. et al. 1994. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371: 606-609.
2. OFFIELD, M.F. et al. 1996. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122: 983-995.
3. HARRISON, K.A. et al. 1999. Pancreas dorsal lobe agenesis and abnormal islets of Langerhans in Hlxb9-deficient mice. Nat. Genet. 23: 71-75.
4. LI, H. et al. 1999. Selective agenesis of the dorsal pancreas in mice lacking homeobox gene Hlxb9. Nat. Genet. 23: 67-70.
5. Ahlgren, U. et al. 1997. Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature 385: 257-260.
6. SOSA-PINEDA, B. et al. 1997. The Pax4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas. Nature 386: 399-402.
7. ST-ONGE, L. et al. 1997. Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas. Nature 387: 406-409.
8. SANDER, M. et al. 1997. Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes & Dev. 11: 1662-1673.
9. SANDER, M. et al. 2000. Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development 127: 5533-5540.
10. SUSSEL, L. et al. 1998. Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. Development 125: 2213-2221.
11. PONTOGLIO, M. et al. 1998. Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. J. Clin. Invest. 101: 2215-2222.
12. LEE, Y.H., B. SAUER & F.J. GONZALEZ. 1998. Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1alpha knockout mouse. Mol. Cell Biol. 18: 3059-3068.
13. NAYA, F.J. et al. 1997. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes & Dev. 11: 2323-2334.
14. CHU, K., E. NEMOZ-GAILLARD & M.J. TSAI. 2001. BETA2 and pancreatic islet development. Recent Prog. Horm. Res. 56: 23-46.
15. HUANG, H.P. et al. 2002. Neogenesis of beta-cells in adult BETA2/NeuroD-deficient mice. Mol. Endocrinol. 16: 541-551.
16. GRADWOHL, G. et al. 2000. Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc. Natl. Acad. Sci. USA 97: 1607-1611.
17. SCHWITZGEBEL, V.M. et al. 2000. Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Development 127: 3533-3542.
18. GU, G., J.R. BROWN & D.A. MELTON. 2003. Direct lineage tracing reveals the ontogeny of pancreatic cell fates during mouse embryogenesis. Mech. Dev. 120: 35-43.
19. EDLUND, H. 1998. Transcribing pancreas. Diabetes 47: 1817-1823.
20. SCHWITZGEBEL, V.M. 2001. Programming of the pancreas. Mol. Cell Endocrinol. 185: 99-108.
21. EDLUND, H. 2001. Factors controlling pancreatic cell differentiation and function. Diabetologia 44: 1071-1079.
22. WILSON, M.E., D. SCHEEL & M.S. GERMAN. 2003. Gene expression cascades in pancreatic development. Mech. Dev. 120: 65-80.
23. GUZ, Y. et al. 1995. Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development 121: 11-18.
24. SLACK, J.M. 1995. Developmental biology of the pancreas. Development 121: 1569-1580.
25. AHLGREN, U., J. JONSSON & H. EDLUND. 1996. The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient mice. Development 122: 1409-1416.
26. STOFFERS, D.A. et al. 1997. Pancreatic agenesis attributable to a single nucleotide deletion in die human IPF1 gene coding sequence. Nat. Genet. 15: 106-110.
27. JONSSON, J. et al. 1995. TPF1, a homeodomain protein with a dual function in pancreas development. Int. J. Dev. Biol. 39: 789-798.
28. STOFFERS, D.A. et al. 1999. Developmental expression of the homeodomain protein IDX-1 in mice transgenic for an IDX-1 promoter/lacZ transcriptional reporter. Endocrinology 140: 5374-5381.
29. AHLGREN, U. et al. 1998. Beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes & Dev. 12: 1763-1768.
30. BRISSOVA, M. et al. 2002. Reduction in pancreatic transcription factor PDX-1 impairs glucose- stimulated insulin secretion. J. Biol. Chem. 277: 11225-11232.
31. JOHNSON, J.D. et al. 2003. Increased islet apoptosis in Pdx1+/- mice. J. Clin. Invest. 111: 1147-1160.
32. MELLOUL, D., N. KAISER & E. CERASI. 2000. Chronic exposure to high glucose impairs multiple β-cell functions in cultured human pancreatic islets. Curr. Opin. Endocrinol. Diabetes 7: 44-48.
33. POITOUT, V. & R.P. ROBERTSON. 2002. Minireview: secondary beta-cell failure in type 2 diabetes: a convergence of glucotoxicity and lipotoxicity. Endocrinology 143: 339-342.
34. MELLOUL, D., A. TSUR & D. ZANGEN. 2002. Pancreatic duodenal homeobox (PDX-1) in health and disease. J. Pediatr. Endocrinol. Metab. 15: 1461-1472.
35. ROBERTSON, R.P. et al. 2003. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52: 581-587.
36. GERMAN, M.S. 1993. Glucose sensing in pancreatic islet beta cells: the key role of glucokinase and the glycolytic intermediates. Proc. Natl. Acad. Sci. USA 90: 1781-1785.
37. MCKINNON, C.M. & K. DOCHERTY. 2001. Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function. Diabetologia 44: 1203-1214.
38. WAEBER, G. et al. 1996. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Mol. Endocrinol. 10: 1327-1334.
39. WATADA, H. et al. 1996. The human glucokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells. Diabetes 45: 1478-1488.
40. WATADA, H. et al. 1996. Involvement of the homeodomain-containing transcription factor PDX-1 in islet amyloid polypeptide gene transcription. Biochem. Biophys. Res. Commun. 229: 746-751.
41. BrETHERTON-WATT, D., N. GORE & D.S. BOAM. 1996. Insulin upstream factor 1 and a novel ubiquitous factor bind to the human islet amyloid polypeptide/amylin gene promoter. Biochem. J. 313 (Pt 2): 495-502.
42. CARTY, M.D. et al. 1997. Identification of cis- and trans-active factors regulating human islet amyloid polypeptide gene expression in pancreatic beta-cells. J. Biol. Chem. 272: 11986-11993.
43. LEONARD, J. et al. 1993. Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells. Mol. Endocrinol. 7: 1275-1283.
44. MILLER, C.P., R.E. MCGEHEE, JR. & J.F. HABENER. 1994. IDX-1: a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene. EMBO J. 13: 1145-1156.
45. GITTES, G.K. & W.J. RUTTER. 1992. Onset of cell-specific gene expression in the developing mouse pancreas. Proc. Natl. Acad. Sci. USA 89: 1128-1132.
46. POLAK, M. et al. 2000. Early pattern of differentiation in the human pancreas. Diabetes 49: 225-232.
47. MELLOUL, D., S. MARSHAK & E. CERASI. 2002. Regulation of insulin gene transcription. Diabetologia 45: 309-326.
48. MELLOUL, D., Y. BEN-NERIAH & E. CERASI. 1993. Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoters. Proc. Natl. Acad. Sci. USA 90: 3865-3869.
49. 2+. Diabetes 49: 418-423.
50. LEIBOWITZ, G. et al. 2001. Defective glucose-regulated insulin gene expression associated with PDX-1 deficiency in the Psammomys obesus model of type 2 diabetes. Diabetes 50 (suppl 1): S138-139.
51. FERRER, J. et al. 1993. Signals derived from glucose metabolism are required for glucose regulation of pancreatic islet GLUT2 mRNA and protein. Diabetes 42: 1273-1280.
52. LEAHY, J.L. 1996. Beta-cell dysfunction with chronic hyperglycemia: "overworked beta-cell" hypothesis. Diabetes Rev. 4: 298-319.
53. SHARMA, A. et al. 1995. The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression. Mol. Endocrinol. 9: 1127-1134.
54. POITOUT, V., L.K. OLSON & R.P. ROBERTSON. 1996. Chronic exposure of betaTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator. J. Clin. Invest. 97: 1041-1046.
55. MORAN, A. et al. 1997. Differentiation of glucose toxicity from beta cell exhaustion during the evolution of defective insulin gene expression in the pancreatic islet cell line, HIT-T15. J. Clin. Invest. 99: 534-539.
56. SEUFERT, J., G.C. WEIR & J.F. HABENER. 1998. Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein beta and transactivator islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus. J. Clin. Invest. 101: 2528-2539.
57. ZANGEN, D.H. et al. 1997. Reduced insulin, GLUT2, and IDX-1 in beta-cells after partial pancreatectomy. Diabetes 46: 258-264.
58. JONAS, J.C. et al. 1999. Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J. Biol. Chem. 274: 14112-14121.
59. DAVALLI, A.M. et al. 1991. Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium. J. Clin. Endocrinol. Metab. 72: 202-208.
60. EIZIRIK, D.L., G.S. KORBUTT & C. HELLERSTROM. 1992. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. J. Clin. Invest. 90: 1263-1268.
61. MARSHAK, S. et al. 1999. Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes 48: 1230-1236.
62. HARMON, J.S. et al. 1999. In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression. Diabetes 48: 1995-2000.
63. LAYBUTT, D.R. et al. 2003. Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes. J. Biol. Chem. 278: 2997-3005.
64. SHARMA, A. et al. 1999. The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes 48: 507-513.
65. SHARMA, S. et al. 1996. Pancreatic islet expression of the homeobox factor STF-1 relies on an E- box motif that binds USF. J. Biol. Chem. 271: 2294-2299.
66. DUTTA, S. et al. 2001. PDX:PBX complexes are required for normal proliferation of pancreatic cells during development. Proc. Natl. Acad. Sci. USA 98: 1065-1070.
67. GUALDI, R. et al. 1996. Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control. Genes & Dev. 10: 1670-1682.
68. ZARET, K.S. 1996. Molecular genetics of early liver development. Annu. Rev. Physiol. 58: 231-251.
69. KAESTNER, K.H. 2000. The hepatocyte nuclear factor 3 (HNF3 or FOXA) family in metabolism. Trends Endocrinol. Metab. 11: 281-285.
70. SHARMA, S. et al. 1997. Hormonal regulation of an islet-specific enhancer in the pancreatic homeobox gene STF-1. Mol. Cell Biol. 17: 2598-2604.
71. BEN-SHUSHAN, E. et al. 2001. A pancreatic beta -cell-specific enhancer in the human PDX-1 gene is regulated by hepatocyte nuclear factor 3beta (HNF-3beta), HNF-1alpha, and SPs transcription factors. J. Biol. Chem. 276: 17533-17540.
72. LEE, C.S. et al. 2002. Foxa2 controls Pdx1 gene expression in pancreatic beta-cells in vivo. Diabetes 51: 2546-2551.
73. MARSHAK, S., E. BENSHUSHAN, M. SHOSHKES, et al. 2000. Functional conservation of regulatory elements in the PDX-1 gene: PDX-1 and HNF3β transcription factors mediate β-cell specific expression. Mol. Cell Biol. 20: 7583-7589.
74. GERRISH, K. et al. 2000. Pancreatic beta cell-specific transcription of the pdx-1 gene. The role of conserved upstream control regions and their hepatic nuclear factor 3beta sites. J. Biol. Chem. 275: 3485-3492.
75. MELLOUL, D., S. MARSHAK & E. CERASI. 2002. Regulation of pdx-1 gene expression. Diabetes. 51 (Suppl 3): S320-325.
76. SAMARAS, S.E. et al. 2003. The islet beta cell-enriched RIPE3b1/Maf transcription factor regulates pdx-1 expression. J. Biol. Chem. 278: 12263-12270.
77. STOFFERS, D.A., V. STANOJEVIC & J.F. HABENER. 1998. Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein. J. Clin. Invest. 102: 232-241.
78. MACFARLANE, W.M. et al. 1999. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J. Clin. Invest. 104: R33-39.
79. FAJANS, S.S., G.I. BELL & K.S. POLONSKY. 2001. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med. 345: 971-980.